JP7321410B2 - Norovirus inactivation method - Google Patents
Norovirus inactivation method Download PDFInfo
- Publication number
- JP7321410B2 JP7321410B2 JP2018070445A JP2018070445A JP7321410B2 JP 7321410 B2 JP7321410 B2 JP 7321410B2 JP 2018070445 A JP2018070445 A JP 2018070445A JP 2018070445 A JP2018070445 A JP 2018070445A JP 7321410 B2 JP7321410 B2 JP 7321410B2
- Authority
- JP
- Japan
- Prior art keywords
- extract
- indigo
- tryptanthrin
- limonene
- hours
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Active
Links
- 241001263478 Norovirus Species 0.000 title claims description 10
- 238000000034 method Methods 0.000 title claims description 7
- 230000002779 inactivation Effects 0.000 title description 3
- VQQVWGVXDIPORV-UHFFFAOYSA-N Tryptanthrine Chemical compound C1=CC=C2C(=O)N3C4=CC=CC=C4C(=O)C3=NC2=C1 VQQVWGVXDIPORV-UHFFFAOYSA-N 0.000 claims description 98
- XMGQYMWWDOXHJM-JTQLQIEISA-N (+)-α-limonene Chemical compound CC(=C)[C@@H]1CCC(C)=CC1 XMGQYMWWDOXHJM-JTQLQIEISA-N 0.000 claims description 74
- 235000000177 Indigofera tinctoria Nutrition 0.000 claims description 51
- 229940097275 indigo Drugs 0.000 claims description 51
- COHYTHOBJLSHDF-UHFFFAOYSA-N indigo powder Natural products N1C2=CC=CC=C2C(=O)C1=C1C(=O)C2=CC=CC=C2N1 COHYTHOBJLSHDF-UHFFFAOYSA-N 0.000 claims description 50
- 239000000284 extract Substances 0.000 claims description 46
- 230000000415 inactivating effect Effects 0.000 claims description 2
- 241001062009 Indigofera Species 0.000 description 51
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 32
- 238000000605 extraction Methods 0.000 description 29
- 239000000243 solution Substances 0.000 description 27
- CIWBSHSKHKDKBQ-JLAZNSOCSA-N Ascorbic acid Chemical compound OC[C@H](O)[C@H]1OC(=O)C(O)=C1O CIWBSHSKHKDKBQ-JLAZNSOCSA-N 0.000 description 24
- XMGQYMWWDOXHJM-UHFFFAOYSA-N limonene Chemical compound CC(=C)C1CCC(C)=CC1 XMGQYMWWDOXHJM-UHFFFAOYSA-N 0.000 description 22
- IAZDPXIOMUYVGZ-UHFFFAOYSA-N Dimethylsulphoxide Chemical compound CS(C)=O IAZDPXIOMUYVGZ-UHFFFAOYSA-N 0.000 description 18
- 235000010323 ascorbic acid Nutrition 0.000 description 12
- 239000011668 ascorbic acid Substances 0.000 description 12
- 229960005070 ascorbic acid Drugs 0.000 description 12
- 230000003385 bacteriostatic effect Effects 0.000 description 12
- 229940087305 limonene Drugs 0.000 description 11
- 235000001510 limonene Nutrition 0.000 description 11
- 241000714201 Feline calicivirus Species 0.000 description 8
- 239000000469 ethanolic extract Substances 0.000 description 8
- 239000006145 Eagle's minimal essential medium Substances 0.000 description 7
- 241000700605 Viruses Species 0.000 description 7
- 230000000694 effects Effects 0.000 description 7
- 238000002474 experimental method Methods 0.000 description 7
- 239000000203 mixture Substances 0.000 description 6
- 150000001875 compounds Chemical class 0.000 description 5
- 238000001035 drying Methods 0.000 description 5
- 239000002035 hexane extract Substances 0.000 description 5
- 239000000126 substance Substances 0.000 description 5
- 241000196324 Embryophyta Species 0.000 description 4
- 244000283207 Indigofera tinctoria Species 0.000 description 4
- 240000004808 Saccharomyces cerevisiae Species 0.000 description 4
- 235000014680 Saccharomyces cerevisiae Nutrition 0.000 description 4
- 239000003153 chemical reaction reagent Substances 0.000 description 4
- 229930002875 chlorophyll Natural products 0.000 description 4
- 235000019804 chlorophyll Nutrition 0.000 description 4
- ATNHDLDRLWWWCB-AENOIHSZSA-M chlorophyll a Chemical compound C1([C@@H](C(=O)OC)C(=O)C2=C3C)=C2N2C3=CC(C(CC)=C3C)=[N+]4C3=CC3=C(C=C)C(C)=C5N3[Mg-2]42[N+]2=C1[C@@H](CCC(=O)OC\C=C(/C)CCC[C@H](C)CCC[C@H](C)CCCC(C)C)[C@H](C)C2=C5 ATNHDLDRLWWWCB-AENOIHSZSA-M 0.000 description 4
- 238000004043 dyeing Methods 0.000 description 4
- 238000007654 immersion Methods 0.000 description 4
- VLKZOEOYAKHREP-UHFFFAOYSA-N n-Hexane Chemical compound CCCCCC VLKZOEOYAKHREP-UHFFFAOYSA-N 0.000 description 4
- WEVYAHXRMPXWCK-UHFFFAOYSA-N Acetonitrile Chemical compound CC#N WEVYAHXRMPXWCK-UHFFFAOYSA-N 0.000 description 3
- 238000004040 coloring Methods 0.000 description 3
- 238000010790 dilution Methods 0.000 description 3
- 239000012895 dilution Substances 0.000 description 3
- 238000004128 high performance liquid chromatography Methods 0.000 description 3
- 238000004519 manufacturing process Methods 0.000 description 3
- 239000002609 medium Substances 0.000 description 3
- 239000000047 product Substances 0.000 description 3
- 239000002904 solvent Substances 0.000 description 3
- 239000012085 test solution Substances 0.000 description 3
- 241000894006 Bacteria Species 0.000 description 2
- 108091003079 Bovine Serum Albumin Proteins 0.000 description 2
- 241000282324 Felis Species 0.000 description 2
- 241000219050 Polygonaceae Species 0.000 description 2
- 244000292697 Polygonum aviculare Species 0.000 description 2
- 235000006386 Polygonum aviculare Nutrition 0.000 description 2
- 239000004480 active ingredient Substances 0.000 description 2
- 238000004113 cell culture Methods 0.000 description 2
- 238000001514 detection method Methods 0.000 description 2
- 239000000706 filtrate Substances 0.000 description 2
- 208000015181 infectious disease Diseases 0.000 description 2
- 239000007788 liquid Substances 0.000 description 2
- 230000000813 microbial effect Effects 0.000 description 2
- 230000001590 oxidative effect Effects 0.000 description 2
- 238000002360 preparation method Methods 0.000 description 2
- 238000010079 rubber tapping Methods 0.000 description 2
- 238000003756 stirring Methods 0.000 description 2
- 239000006228 supernatant Substances 0.000 description 2
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 2
- PUPZLCDOIYMWBV-UHFFFAOYSA-N (+/-)-1,3-Butanediol Chemical compound CC(O)CCO PUPZLCDOIYMWBV-UHFFFAOYSA-N 0.000 description 1
- 150000000130 (4R)-limonene 1,2-epoxide derivatives Chemical class 0.000 description 1
- 229920001817 Agar Polymers 0.000 description 1
- 241000219193 Brassicaceae Species 0.000 description 1
- 208000035473 Communicable disease Diseases 0.000 description 1
- 241001464430 Cyanobacterium Species 0.000 description 1
- SBJKKFFYIZUCET-JLAZNSOCSA-N Dehydro-L-ascorbic acid Chemical compound OC[C@H](O)[C@H]1OC(=O)C(=O)C1=O SBJKKFFYIZUCET-JLAZNSOCSA-N 0.000 description 1
- SBJKKFFYIZUCET-UHFFFAOYSA-N Dehydroascorbic acid Natural products OCC(O)C1OC(=O)C(=O)C1=O SBJKKFFYIZUCET-UHFFFAOYSA-N 0.000 description 1
- 241000221017 Euphorbiaceae Species 0.000 description 1
- 241000220485 Fabaceae Species 0.000 description 1
- 206010016952 Food poisoning Diseases 0.000 description 1
- 208000019331 Foodborne disease Diseases 0.000 description 1
- 241000233866 Fungi Species 0.000 description 1
- 206010020649 Hyperkeratosis Diseases 0.000 description 1
- ZDXPYRJPNDTMRX-VKHMYHEASA-N L-glutamine Chemical compound OC(=O)[C@@H](N)CCC(N)=O ZDXPYRJPNDTMRX-VKHMYHEASA-N 0.000 description 1
- 229930182816 L-glutamine Natural products 0.000 description 1
- 229930040373 Paraformaldehyde Natural products 0.000 description 1
- FAPWRFPIFSIZLT-UHFFFAOYSA-M Sodium chloride Chemical compound [Na+].[Cl-] FAPWRFPIFSIZLT-UHFFFAOYSA-M 0.000 description 1
- 238000002835 absorbance Methods 0.000 description 1
- 239000002253 acid Substances 0.000 description 1
- 239000008272 agar Substances 0.000 description 1
- 238000007605 air drying Methods 0.000 description 1
- 229930013930 alkaloid Natural products 0.000 description 1
- 238000004458 analytical method Methods 0.000 description 1
- 230000000844 anti-bacterial effect Effects 0.000 description 1
- 230000000840 anti-viral effect Effects 0.000 description 1
- 239000003963 antioxidant agent Substances 0.000 description 1
- 230000003078 antioxidant effect Effects 0.000 description 1
- 235000006708 antioxidants Nutrition 0.000 description 1
- 239000003443 antiviral agent Substances 0.000 description 1
- 238000006701 autoxidation reaction Methods 0.000 description 1
- 230000001580 bacterial effect Effects 0.000 description 1
- 239000007844 bleaching agent Substances 0.000 description 1
- 238000007664 blowing Methods 0.000 description 1
- 238000009395 breeding Methods 0.000 description 1
- 230000001488 breeding effect Effects 0.000 description 1
- 230000003833 cell viability Effects 0.000 description 1
- 239000012916 chromogenic reagent Substances 0.000 description 1
- 230000000052 comparative effect Effects 0.000 description 1
- 238000007796 conventional method Methods 0.000 description 1
- 239000013078 crystal Substances 0.000 description 1
- ZXJXZNDDNMQXFV-UHFFFAOYSA-M crystal violet Chemical compound [Cl-].C1=CC(N(C)C)=CC=C1[C+](C=1C=CC(=CC=1)N(C)C)C1=CC=C(N(C)C)C=C1 ZXJXZNDDNMQXFV-UHFFFAOYSA-M 0.000 description 1
- 238000012364 cultivation method Methods 0.000 description 1
- 230000000120 cytopathologic effect Effects 0.000 description 1
- 238000000354 decomposition reaction Methods 0.000 description 1
- 238000007872 degassing Methods 0.000 description 1
- 230000007850 degeneration Effects 0.000 description 1
- 235000020960 dehydroascorbic acid Nutrition 0.000 description 1
- 239000011615 dehydroascorbic acid Substances 0.000 description 1
- 238000004925 denaturation Methods 0.000 description 1
- 230000036425 denaturation Effects 0.000 description 1
- 125000004989 dicarbonyl group Chemical group 0.000 description 1
- 231100000676 disease causative agent Toxicity 0.000 description 1
- 230000002900 effect on cell Effects 0.000 description 1
- 239000003797 essential amino acid Substances 0.000 description 1
- 235000020776 essential amino acid Nutrition 0.000 description 1
- 238000002481 ethanol extraction Methods 0.000 description 1
- 239000004744 fabric Substances 0.000 description 1
- 238000005562 fading Methods 0.000 description 1
- 230000002349 favourable effect Effects 0.000 description 1
- 239000012091 fetal bovine serum Substances 0.000 description 1
- 239000012894 fetal calf serum Substances 0.000 description 1
- 229960001235 gentian violet Drugs 0.000 description 1
- 239000001963 growth medium Substances 0.000 description 1
- 238000011534 incubation Methods 0.000 description 1
- 230000002458 infectious effect Effects 0.000 description 1
- 230000005764 inhibitory process Effects 0.000 description 1
- 210000003734 kidney Anatomy 0.000 description 1
- 235000021374 legumes Nutrition 0.000 description 1
- 239000012528 membrane Substances 0.000 description 1
- 239000011259 mixed solution Substances 0.000 description 1
- 230000003647 oxidation Effects 0.000 description 1
- 238000007254 oxidation reaction Methods 0.000 description 1
- 229920002866 paraformaldehyde Polymers 0.000 description 1
- 239000000049 pigment Substances 0.000 description 1
- 239000008213 purified water Substances 0.000 description 1
- 239000002994 raw material Substances 0.000 description 1
- 239000011541 reaction mixture Substances 0.000 description 1
- 229920006395 saturated elastomer Polymers 0.000 description 1
- 238000013207 serial dilution Methods 0.000 description 1
- 239000002356 single layer Substances 0.000 description 1
- 238000002791 soaking Methods 0.000 description 1
- VSIVTUIKYVGDCX-UHFFFAOYSA-M sodium;4-[2-(2-methoxy-4-nitrophenyl)-3-(4-nitrophenyl)tetrazol-2-ium-5-yl]benzene-1,3-disulfonate Chemical compound [Na+].COC1=CC([N+]([O-])=O)=CC=C1[N+]1=NC(C=2C(=CC(=CC=2)S([O-])(=O)=O)S([O-])(=O)=O)=NN1C1=CC=C([N+]([O-])=O)C=C1 VSIVTUIKYVGDCX-UHFFFAOYSA-M 0.000 description 1
- 238000005507 spraying Methods 0.000 description 1
- 239000012192 staining solution Substances 0.000 description 1
- 230000035899 viability Effects 0.000 description 1
- 231100000747 viability assay Toxicity 0.000 description 1
- 238000003026 viability measurement method Methods 0.000 description 1
Classifications
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
- Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
- Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
- Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change
Landscapes
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicines Containing Plant Substances (AREA)
Description
本発明は、藍葉に含まれるトリプタンスリンによる抗ウイルス作用を用いたノロウイルス不活性化方法に関するものである。 The present invention relates to a method for inactivating norovirus using the antiviral action of tryptanthrin contained in indigo leaves.
従来から特許文献1に開示されたトリプタンスリン含有藍葉エキス製造方法が知られている。当該製造方法では、タデ藍の天日乾燥葉にエタノールを加えてこれを2時間還流し、室温まで自然冷却した後、メッシュ状のフィルタにより葉を濾過する。このようにして得た濾液(藍葉エタノール抽出液)をロータリーエバポレーターにより減圧蒸留し、所定総量まで濃縮する。そして、当該濃縮濾液にブチレングリコールを加えて当該エキスを溶解させトリプタンスリン含有藍葉エキスを得る。 Conventionally, a method for producing a tryptanthrin-containing indigo leaf extract disclosed in Patent Document 1 is known. In this production method, ethanol is added to the sun-dried leaves of knotweed indigo, and the mixture is refluxed for 2 hours, naturally cooled to room temperature, and then filtered through a mesh filter. The filtrate (indigo leaf ethanol extract) thus obtained is distilled under reduced pressure using a rotary evaporator and concentrated to a predetermined total volume. Then, butylene glycol is added to the concentrated filtrate to dissolve the extract to obtain a tryptanthrin-containing indigo leaf extract.
現在、ノロウイルスによる食中毒や感染症が問題となっており、このノロウイルスに効果のある抗ウイルス剤がないため、早期の解決が望まれている。一方、人体に副作用が出ないようにする必要がある。 Currently, food poisoning and infectious diseases caused by norovirus are a problem, and since there is no antiviral agent effective against this norovirus, an early solution is desired. On the other hand, it is necessary to prevent side effects from appearing on the human body.
本発明に係るノロウイルス不活性化方法では、トリプタンスリン含有藍エキスを用いる。例えば、あおもり藍エキスを100%エタノールで希釈し、0.002μMのトリプタンスリンを含有するあおもり藍エキス溶液を用いる。 In the norovirus inactivation method according to the present invention, a tryptanthrin-containing indigo extract is used. For example, Aomori indigo extract is diluted with 100% ethanol, and Aomori indigo extract solution containing 0.002 μM tryptanthrin is used.
本発明に係る試験では、ノロウイルスとよく似た性質を持つネコカリシウイルス(FCV)を用いた。
(実験結果)
1.ネコカリシウイルス(FCV)の調製
ネコカリシFCV系統F4およびネコ腎由来株化細胞(CRFK)細胞は、10%ウシ胎児血清(FCS; JRH Biosciences、Lenexa、KS)、1% L-グルタミン、および1%ウシ胎児血清を添加したイーグル最小必須培地(EMEM; Nissui Pharmaceutical Co.、Tokyo、Japan) (Wako Pure Chemical Industries、Osaka、Japan)、及び1×非必須アミノ酸(Thermo Fisher Scientific、Waltham、MA)を用いて培養した。
In the tests according to the present invention, feline calicivirus (FCV), which has similar properties to norovirus, was used.
(Experimental result)
1. Preparation of feline calicivirus (FCV) Feline calici FCV strain F4 and feline kidney-derived cell line (CRFK) cells were prepared with 10% fetal calf serum (FCS; JRH Biosciences, Lenexa, Kans.), 1% L-glutamine, and 1% Eagle's minimum essential medium (EMEM; Nissui Pharmaceutical Co., Tokyo, Japan) supplemented with fetal bovine serum (Wako Pure Chemical Industries, Osaka, Japan) and 1× non-essential amino acids (Thermo Fisher Scientific, Waltham, MA) were used. and cultured.
FCVはCRFK単層細胞にウイルス溶液(FCSを含まない2mlのEMEMで希釈したストックFCV溶液20μl)を接種し、37℃、5% CO2環境下で15分ごとにタッピングヲ行いながら1時間インキュベートした。 FCV was inoculated into CRFK monolayer cells with a virus solution (20 μl of stock FCV solution diluted in 2 ml of EMEM without FCS) and incubated at 37° C. in a 5% CO 2 environment for 1 hour with tapping every 15 minutes. bottom.
その後、ウイルス溶液を10% FCSを添加したEMEMで交換し、細胞を37℃、5% CO2環境下で18から24時間連続インキュベートした。細胞変性効果を確認した後、上清を回収し、一度凍結融解し、8,000×g、4℃、20分間の遠心分離により細胞破片を除去した。得られた上清をウイルスストックとして使用した。ストックウイルスは、96穴プレートで増殖させたCRFK細胞に感染させた後、50% 組織培養感染量(TCID50)を算出した。 After that, the virus solution was replaced with EMEM supplemented with 10% FCS, and the cells were continuously incubated at 37° C., 5% CO 2 for 18 to 24 hours. After confirming the cytopathic effect, the supernatant was collected, freeze-thawed once, and centrifuged at 8,000 xg at 4°C for 20 minutes to remove cell debris. The resulting supernatant was used as virus stock. Stock viruses were used to infect CRFK cells grown in 96-well plates before calculating the 50% tissue culture infectious dose (TCID50).
2.ウイルス生存率に対するあおもり藍エキスの影響
CRFK細胞を96穴プレート(1×10<sup>5<sup>細胞/ウェル)に播種し、37℃、5% CO2環境下で12から18時間インキュベートした。あおもり藍エキスを100%エタノールで希釈し、0.002μMのトリプタンスリンを含有する25μlのあおもり藍エキス溶液を75μlのFCVと共に室温で10分間インキュベートした。対照としてはエタノールを使用した。反応混合物の10倍連続希釈物を、FCSを含まないEMEM中で作製し、CRFK細胞に接種した。
2. Effect of Aomori Indigo Extract on Virus Viability CRFK cells were seeded in 96-well plates (1×105 cells/well) and incubated at 37° C., 5% CO 2 for 12 to 18 hours. . Aomori indigo extract was diluted with 100% ethanol, and 25 μl of Aomori indigo extract solution containing 0.002 μM tryptanthrin was incubated with 75 μl of FCV for 10 minutes at room temperature. Ethanol was used as a control. Ten-fold serial dilutions of the reaction mixture were made in EMEM without FCS and inoculated onto CRFK cells.
37℃、5% CO2環境下で15分ごとにタッピングを行いながら1時間インキュベートした後、FCSを含まないEMEMで細胞を3回洗浄し、5% FCSを添加したEMEM中で37℃、5% CO2環境下で72時間インキュベートした。細胞を染色溶液(0.5% ゲンチアナバイオレット、50% エタノール、0.9% NaClおよび1.85% パラホルムアルデヒド)で15分間染色し、細胞生存率を観察した。 After incubating for 1 hour at 37°C in 5% CO2 environment with tapping every 15 minutes, cells were washed 3 times with EMEM without FCS and incubated at 37°C for 5 minutes in EMEM supplemented with 5% FCS. Incubated for 72 hours in % CO2 environment. Cells were stained with staining solution (0.5% gentian violet, 50% ethanol, 0.9% NaCl and 1.85% paraformaldehyde) for 15 minutes and observed for cell viability.
図1に、上記実験結果を示す。藍エキスでは、希釈濃度が10-6から効果が出ているが、エタノールでは希釈濃度が10-8でようやく効果が表れる。このように、藍エキスは、エタノールに比べて100倍近い濃度であってもウイルス力価の低減に効果があることが分かった。即ち、この藍エキスは、ノロウイルスのウイルス力価の低減に効果があるものと考えられる。 FIG. 1 shows the results of the above experiment. The indigo extract shows its effect at a dilution concentration of 10 −6 , but the ethanol finally shows its effect at a dilution concentration of 10 −8 . Thus, it was found that the indigo extract was effective in reducing the virus titer even at a concentration nearly 100 times higher than that of ethanol. That is, this indigo extract is considered to be effective in reducing the virus titer of norovirus.
図2に示すように、藍エキス、エタノールは、細胞に対する効果がない。 As shown in FIG. 2, indigo extract and ethanol have no effect on cells.
本発明の0.002μMのトリプタンスリンを含有するあおもり藍エキス溶液は、スプレーなどにより感染経路となるような物や空間に供給する。これにより、ノロウイルスの不活性化が可能になる。 The Aomori indigo extract solution containing 0.002 μM tryptanthrin of the present invention is supplied to an object or space that may be an infection route by spraying or the like. This allows inactivation of norovirus.
使用するあおもり藍エキスは、例えば、以下のようにして抽出する。 The Aomori indigo extract to be used is extracted, for example, as follows.
本発明に使用できる藍草は、例えば、蓼藍(タデ科)、琉球藍(キツネノマゴ科)、蝦夷藍(ウォード;アブラナ科)、山藍(トウダイグサ科)、インド藍(マメ科)等の含藍植物である。特に、タデ科に属する一年生植物である蓼藍は、入手しやすく且つ特有の成分であるトリプタンスリンを豊富に含んでいることから、使用するに当たり好ましいものとなる。 Indigo plants that can be used in the present invention include, for example, Tate indigo (Polygonaceae), Ryukyu indigo (Polygonaceae), Ezo indigo (Ward; Brassicaceae), Mountain indigo (Euphorbiaceae), Indian indigo (Fabaceae), and the like. It is an indigo plant. In particular, Tateran, an annual plant belonging to the knotweed family, is readily available and rich in tryptanthrin, which is a unique component, and therefore is preferable for use.
また、使用する藍草は、その起源や栽培方法に特に制限はなく、天然に自生する藍草でも、栽培されているものでもよく、これらを常法により育種して得られる変異株などでもよい。また、本発明で使用する藍草は、組織培養、カルス培養、細胞培養等により得ることのできる培養物であってもよい。植物体を抽出の原料として用いる場合、その植物体の一部又は全部を用いることができる。また、植物体は、水分を含む状態、凍結状態、乾燥状態のいずれであってもよいし、これらの混合物であってもよい。取り扱いの容易さからは、乾燥状態のものを用いるのが望ましい。 In addition, the indigo plant to be used is not particularly limited in its origin or cultivation method, and may be naturally occurring indigo plants, cultivated ones, or mutants obtained by breeding these indigo plants by conventional methods. . In addition, the cyanobacterium used in the present invention may be a culture obtained by tissue culture, callus culture, cell culture, or the like. When using a plant as a raw material for extraction, a part or the whole of the plant can be used. Also, the plant body may be in a state containing water, in a frozen state, in a dry state, or in a mixture thereof. From the viewpoint of ease of handling, it is desirable to use the dry state.
加熱乾燥工程では、上記のように収穫した藍草から藍葉のみを採取し、加熱乾燥させる。加熱乾燥は、乾燥装置の乾燥室内に藍葉を入れる。そして、バーナーで加熱した高温の風を送り込みながら、藍葉を撹拌する。風量は、藍葉が乾燥室内で飛ぶ程度に設定し、藍葉全体に均一に風が当たるようにする。 In the heat-drying step, only indigo leaves are collected from the indigo plant harvested as described above, and heat-dried. In heat drying, indigo leaves are placed in the drying chamber of the drying device. Then, the indigo leaves are agitated while blowing high-temperature air heated by a burner. The amount of air is set to the extent that the indigo leaves fly in the drying room, so that the entire indigo leaves are uniformly exposed to the air.
次に、上記加熱乾燥させた藍葉を容器内に所定量投入し、この容器内にd-リモネンの溶液を入れる。d-リモネンの溶液は、藍葉が完全に浸漬される程度に当該容器に入れるのが好ましい。そして、容器内をゆっくりと撹拌した後、一定時間、常温で保持する。温度が高いとd-リモネンが揮発するため、常温以下に保持するのが好ましい。 Next, a predetermined amount of the heat-dried indigo leaves is put into a container, and a solution of d-limonene is put into the container. The solution of d-limonene is preferably placed in the container to such an extent that the indigo leaves are completely immersed. Then, after slowly stirring the inside of the container, the mixture is held at normal temperature for a certain period of time. Since d-limonene volatilizes when the temperature is high, it is preferable to keep the temperature below room temperature.
浸漬時間は、20時間以上30時間以下とするのが好ましい。20時間、24時間、30時間で十分にトリプタンスリンを抽出可能であり、これらの時間による抽出量は48時間、72時間の場合に比較して大きな差がないことが判った。換言すれば、d-リモネンによれば、短時間でトリプタンスリンを十分な量まで抽出可能である。そして、20時間以上30時間以下の短時間での抽出であれば、クロロフィルが溶出することは殆どなく、抽出液の着色は肉眼では認められず、無色透明と評価できるものであった。 The immersion time is preferably 20 hours or more and 30 hours or less. It was found that triptanthrin can be sufficiently extracted at 20 hours, 24 hours and 30 hours, and there is no significant difference in the amount of extraction at these times compared to 48 hours and 72 hours. In other words, d-limonene can extract a sufficient amount of tryptanthrin in a short period of time. When the extraction was carried out for a short time of 20 hours or more and 30 hours or less, almost no chlorophyll was eluted, and the coloration of the extract was not observed with the naked eye, and could be evaluated as colorless and transparent.
これに対し、エタノールによる抽出の場合、24時間の抽出ではd-リモネンよりもトリプタンスリンの抽出量が少なかった。また、エタノールによる抽出の場合、クロロフィルによる着色の度合いが強く、抽出液が黒緑色になった。 In contrast, in the case of extraction with ethanol, the amount of tryptanthrin extracted was less than that of d-limonene after 24 hours of extraction. In addition, in the case of extraction with ethanol, the degree of coloring due to chlorophyll was strong, and the extract turned blackish green.
[抽出効率と着色]
新藍の藍葉に対してd-リモネンとエタノールとによる抽出実験を行った。実験条件として、乾燥させた新藍葉100gにd-リモネン溶液(和光純薬工業,試薬特級)を1.2L加えてすべての藍葉をd-リモネン溶液に浸漬させ、これを撹拌しつつ、24時間、48時間、72時間、96時間で常温保持し、各抽出時間におけるトリプタンスリンの抽出量を測定した。
[Extraction efficiency and coloring]
An extraction experiment using d-limonene and ethanol was performed on indigo leaves of Shin-indigo. As the experimental conditions, 1.2 L of d-limonene solution (Wako Pure Chemical Industries, special reagent grade) was added to 100 g of dried new indigo leaves, and all the indigo leaves were immersed in the d-limonene solution, and this was stirred for 24 hours. , 48 hours, 72 hours, and 96 hours.
比較例として、乾燥させた新藍葉100gにエタノール溶液(和光純薬工業,試薬特級)1.2Lを加えてすべての藍葉を浸漬させ、撹拌しつつ常温保持し、24時間、48時間、72時間、96時間でのトリプタンスリンの抽出量を測定した。 As a comparative example, 1.2 L of ethanol solution (Wako Pure Chemical Industries, special reagent grade) was added to 100 g of dried new indigo leaves, all the indigo leaves were immersed, and the mixture was kept at room temperature while stirring for 24 hours, 48 hours, and 72 hours. , the amount of tryptanthrin extracted at 96 hours was measured.
この結果、d-リモネンによる抽出において、その抽出時間が24時間の場合、抽出液のトリプタンスリンの含有量は81μg/gであった。抽出時間が48時間、72時間の場合では、抽出液のトリプタンスリンの含有量は、98μg/g前後である。この実験結果から、48時間、72時間と抽出時間を倍増しても、トリプタンスリンの抽出量は比例して増大することはなく、24時間の抽出時間の場合と大差がないことが判った。この実験結果より、24時間程度でトリプタンスリンを所定量まで急速に抽出できることが判った。また、抽出時間が24時間の抽出液は無色透明であり、クロロフィルの出現は目視では確認できなかった。 As a result, in the extraction with d-limonene, when the extraction time was 24 hours, the tryptanthrin content of the extract was 81 μg/g. When the extraction time is 48 hours and 72 hours, the tryptanthrin content of the extract is around 98 μg/g. From this experimental result, it was found that even if the extraction time was doubled to 48 hours and 72 hours, the amount of tryptanthrin extracted did not increase proportionally, and there was not much difference from the case of 24 hours extraction time. From this experimental result, it was found that triptanthrin can be rapidly extracted up to a predetermined amount in about 24 hours. Moreover, the extract obtained after the extraction time was 24 hours was colorless and transparent, and the appearance of chlorophyll could not be visually confirmed.
一方、エタノールによる抽出では、抽出時間が24時間でトリプタンスリンの含有量が73μg/gであり、d-リモネンの場合よりも若干少ない抽出量となった。また、48時間では137μg/g、72時間では232μg/gと時間に比例してトリプタンスリンの抽出量が増えたが、24時間~72時間の抽出時間のすべての場合において、クロロフィルの出現が極めて強く、抽出液が黒緑色になった。 On the other hand, in the extraction with ethanol, the extraction time was 24 hours, and the tryptanthrin content was 73 μg/g, which was slightly smaller than that in the case of d-limonene. The amount of tryptanthrin extracted was 137 μg/g at 48 hours and 232 μg/g at 72 hours, and the amount of triptanthrin extracted increased in proportion to time. Strongly, the extract turned blackish green.
以上の実験結果から、d-リモネンにより藍葉の24時間の抽出を行うことで、クロロフィルの出現を抑えて効率的にトリプタンスリンを抽出できることが判った。 From the above experimental results, it was found that by extracting indigo leaves with d-limonene for 24 hours, tryptanthrin can be efficiently extracted while suppressing the appearance of chlorophyll.
次の実験では、1,5,10,15,20,25,30時間の短時間でトリプタンスリンの抽出量の変化を測定した。この実験では、抽出溶媒としてn-ヘキサン(和光純薬工業,試薬特級),上記エタノール,上記d-リモネンの3種の溶媒を用いトリプタンスリンの抽出量を比較した。具体的には、藍葉0.5gに抽出溶媒を5mL加え,日本薬局方通則15の冷浸法に従い,室温暗所にて冷浸した。その後、継時的に1,5,10,15,20,25,30時間で抽出液を採取し,メンブレンフィルターでろ過し,HPLC用の試料とした。 In the next experiment, changes in the amount of tryptanthrin extracted were measured for short periods of 1, 5, 10, 15, 20, 25 and 30 hours. In this experiment, three kinds of solvents, ie, n-hexane (Wako Pure Chemical Industries, special reagent grade), the above ethanol, and the above d-limonene were used as extraction solvents, and the amounts of tryptanthrin extracted were compared. Specifically, 5 mL of an extraction solvent was added to 0.5 g of indigo leaves, and the mixture was soaked at room temperature in a dark place according to the cold soaking method of General Rule 15 of the Japanese Pharmacopoeia. After that, extracts were collected successively at 1, 5, 10, 15, 20, 25 and 30 hours, filtered with a membrane filter, and used as samples for HPLC.
HPLC装置および分析条件
検出器:SPD-20A (SHIMADZU)
送液ポンプ:LC-20AD (SHIMADZU)
脱気ユニット:DGU-20A3R(SHIMADZU)
カラム:COSMOSIL 5PE-MS 4.6×250mm (nacalai tesque)
移動相:40%アセトニトリル(Sigma-Aldrich)
流速:0.7 ml/min
検出波長:250nm
HPLC device and analysis condition detector: SPD-20A (SHIMADZU)
Liquid sending pump: LC-20AD (SHIMADZU)
Degassing unit: DGU-20A3R (SHIMADZU)
Column: COSMOSIL 5PE-MS 4.6 x 250 mm (nacalai tesque)
Mobile phase: 40% acetonitrile (Sigma-Aldrich)
Flow rate: 0.7 ml/min
Detection wavelength: 250 nm
冷浸開始5時間後ではn-ヘキサン抽出液、d-リモネン抽出液およびエタノール抽出液中のトリプタンスリン含量は、それぞれ18.0188μg/ml,36.2266μg/ml及び38.6007μg/mlであった。d-リモネンおよびエタノールによる抽出量はn-ヘキサンによる抽出量の約2倍となった。 Five hours after the start of cold immersion, the tryptanthrin contents in the n-hexane extract, d-limonene extract and ethanol extract were 18.0188 μg/ml, 36.2266 μg/ml and 38.6007 μg/ml, respectively. . The extraction amounts with d-limonene and ethanol were about twice that with n-hexane.
n-ヘキサン抽出液中のトリプタンスリン含量は、開始30時間後には開始1時間後の含量(16.2836μg/ml)に比較し、31.1338μg/mlと約2倍に上昇したが、その時点ではエタノール抽出液およびリモネン抽出液では顕著な含量の上昇が認められ、ヘキサン抽出液(31.1338μg/ml)に比較し、エタノール抽出液では73.0444μg/ml、リモネン抽出液では96.9976μg/mlとそれぞれ2.35倍および3.12倍の抽出効率が得られることが判った。 The tryptanthrin content in the n-hexane extract was approximately doubled to 31.1338 μg/ml 30 hours after the start compared to the content (16.2836 μg/ml) one hour after the start (16.2836 μg/ml). In the ethanol extract and the limonene extract, a marked increase in the content was observed, compared to the hexane extract (31.1338 μg/ml), the ethanol extract was 73.0444 μg/ml, and the limonene extract was 96.9976 μg/ml. It was found that 2.35-fold and 3.12-fold extraction efficiencies were obtained with ml, respectively.
一方、エタノール抽出液とd-リモネン抽出液との比較では、冷浸開始10時間後からその抽出効率に変化が認められ、冷浸開始20時間後にはエタノール抽出液で58.3826μg/ml、d-リモネン抽出液で72.2422μg/mlであり、約1.3倍の抽出効率の差異が認められた。 On the other hand, in a comparison between the ethanol extract and the d-limonene extract, a change in the extraction efficiency was observed from 10 hours after the start of cold immersion, and 20 hours after the start of cold immersion, the ethanol extract was 58.3826 μg / ml, d - The limonene extract was 72.2422 μg/ml, and a difference in extraction efficiency of about 1.3 times was observed.
更に、上記各抽出液には、色調に大きな差異が認められた。30時間後の抽出液の色調は、n-ヘキサン抽出液で黄緑褐色、エタノール抽出液で淡緑黒色の強い着色が見られた。d-リモネン抽出液では無色に近い淡黄色であった。また、短時間抽出においては、n-ヘキサン抽出液及びエタノール抽出液に比較して、d-リモネン抽出液のトリプタンスリン含量が多くなることが判った。すなわち、d-リモネンによれば、短時間でトリプタンスリンを効率的に抽出し且つ無色の抽出液が得られることが判った。 Furthermore, a large difference in color tone was observed between the above extracts. After 30 hours, the color tone of the extract was yellowish greenish brown in the n-hexane extract, and pale greenish black in the ethanol extract. The d-limonene extract was almost colorless and pale yellow. In addition, in the short-time extraction, it was found that the tryptanthrin content of the d-limonene extract was higher than that of the n-hexane extract and the ethanol extract. That is, it was found that d-limonene can efficiently extract tryptanthrin in a short time and yield a colorless extract.
[静菌活性]
藍葉トリプタンスリンのd-リモネン抽出液によれば、高い静菌活性が得られる。本来、トリプタンスリンもd-リモネンも単独で同作用を有することが知られている。また、トリプタンスリンとd-リモネンを混合して用いることも考えられる。しかしながら、d-リモネンにより藍葉からトリプタンスリンを抽出した抽出液は、これらの単独使用又は混合使用に比べて、顕著なる静菌作用を発揮することが実験の結果、判った。
[Bacteriostatic activity]
The d-limonene extract of indigo leaf tryptanthrin provides high bacteriostatic activity. Originally, both tryptanthrin and d-limonene alone are known to have the same effect. A mixture of tryptanthrin and d-limonene may also be used. However, as a result of experiments, it was found that the extract obtained by extracting tryptanthrin from indigo leaves with d-limonene exerts a remarkable bacteriostatic action compared to the single use or mixed use thereof.
静菌活性の測定は以下のように行った。
パールコア(登録商標)ミューラーヒントンS寒天培地(栄研化学)38gを精製水1000mlに溶解し、115℃で30分オートクレーブ(ES-245、TOMY)処理し、1シャーレ(Cell Culture Dish 100mm×20mm Style、NEST者)に20mL~25mL分注しこれを培地とした。試験菌として酵母菌(Saccharomyces cerevisiae)を用いた。菌数は血球計算盤(C-Chip DHC-N01 NanoEnTek inc.)を用いてカウントし107CFUとした。
Bacteriostatic activity was measured as follows.
Pearlcore (registered trademark) Mueller Hinton S agar medium (Eiken Chemical) 38 g was dissolved in 1000 ml of purified water, autoclaved (ES-245, TOMY) at 115 ° C. for 30 minutes, and placed in one petri dish (Cell Culture Dish 100 mm × 20 mm Style , NEST) and 20 mL to 25 mL of this was used as a medium. Yeast (Saccharomyces cerevisiae) was used as a test fungus. The number of bacteria was counted using a hemocytometer (C-Chip DHC-N01 NanoEnTek Inc.) and set to 107 CFU.
被験液として、(1)トリプタンスリンのDMSO溶液、(2)d-リモネン単独液 、(3)トリプタンスリンのDMSO溶液+d-リモネン単独液、 (4)藍葉トリプタンスリンのd-リモネン抽出液(あおもり藍産業協同組合乾燥藍葉8.33 w/v %)の4種を(1)~(3)は10μM~0.001μMまでの濃度に、(4)は抽出液原液から10-6希釈液までDMSOにて希釈して調製した。96穴マイクロプレート1wellにつき液体培地180μL(ブランク185μL)、菌液5μL、サンプル5μLを分注し38℃で3hインキュベートした。各被験液の静菌活性は微生物比色検出キット (MicrobialViability Asssay Kit-WST 同人化学)を用い測定した。すなわち、上記培養液に発色試薬WST-8を10μL /well添加し、さらに1時間インキュベート後の450nmの吸光度を測定し静菌活性値とし、その濃度依存性からMIC50値を算出した。試験菌としてSaccharomyces cerevisiaeを用いるため、発色試薬はDMSOで8倍希釈したものを用事調製とし用いた。 (1) DMSO solution of tryptanthrin, (2) d-limonene solution alone, (3) DMSO solution of tryptanthrin + d-limonene solution alone, (4) d-limonene extract of indigo leaf tryptanthrin (Aomori Indigo industry cooperative dried indigo leaves 8.33 w / v %) (1) to (3) at concentrations from 10 μM to 0.001 μM, (4) from extract undiluted solution to 10-6 diluted solution Prepared by dilution in DMSO. 180 μL of liquid medium (185 μL of blank), 5 μL of bacterial solution, and 5 μL of sample were dispensed per well of a 96-well microplate and incubated at 38° C. for 3 hours. The bacteriostatic activity of each test solution was measured using a microbial colorimetric detection kit (Microbial Viability Assay Kit-WST Doujin Kagaku). That is, 10 μL/well of the chromogenic reagent WST-8 was added to the above culture medium, and the absorbance at 450 nm after further incubation for 1 hour was measured as the bacteriostatic activity value, and the MIC50 value was calculated from its concentration dependence. Since Saccharomyces cerevisiae was used as the test bacterium, the coloring reagent was diluted 8-fold with DMSO and used as a fresh preparation.
実験結果1
被験液(1)~(4)のそれぞれの阻害率から求めたMIC50値(ng /μL)を以下に示す。
Saccharomyces cerevisiaeに対する静菌作用
(1)トリプタンスリンDMSO溶液 460
(2)d-リモネン 300
(3)トリプタンスリンDMSO溶液+d-リモネン 560
(4)藍葉トリプタンスリンのd-リモネン抽出液 3
Experimental result 1
The MIC50 values (ng/μL) obtained from the respective inhibition rates of test solutions (1) to (4) are shown below.
Bacteriostatic action against Saccharomyces cerevisiae (1) Tryptanthrin DMSO solution 460
(2) d-limonene 300
(3) Tryptanthrin DMSO solution + d-limonene 560
(4) d-limonene extract of indigo leaf tryptanthrin 3
被験液(1)と(2)の単独溶液においては、(1)のトリプタンスリン単独溶液のMIC50値は460 ng/μLであり,d-リモネン単独溶液のMIC50値は300 ng/μLであった。この(1)と(2)の等量混合溶液を使用した(3)においては、それぞれを単独で用いたMIC50値よりもその値は高く560 ng/μLであった。この実験結果から、トリプタンスリン溶液とd-リモネン溶液を混合して用いても、その静菌効果の増強は認められなかった。 In the test solutions (1) and (2) alone, the MIC50 value of the tryptanthrin alone solution (1) was 460 ng/μL, and the MIC50 value of the d-limonene alone solution was 300 ng/μL. . The MIC50 value of (3), in which an equivalent mixed solution of (1) and (2) was used, was 560 ng/μL, which was higher than the MIC50 value when each was used alone. From the results of this experiment, even if the tryptanthrin solution and the d-limonene solution were used in combination, no enhancement of the bacteriostatic effect was observed.
一方、d-リモネンで藍葉からトリプタンスリンを抽出した(4)を用いた場合、そのMIC50値は3ng/μLであり単独使用の(1)または(2)に比較し,その効果は約100倍近く強く、著しくその効果が増強したことから、藍葉トリプタンスリンのd-リモネン抽出液の静菌作用はそれぞれの単独使用時よりもその作用が大きく増加することが判った。 On the other hand, when tryptanthrin is extracted from indigo leaves with d-limonene (4), its MIC50 value is 3 ng/μL, which is about 100 times more effective than single use (1) or (2). It was found that the bacteriostatic action of the d-limonene extract of indigo leaf tryptanthrin was significantly increased compared to when each of them was used alone.
上記HPLC装置により測定したチャートによれば、d-リモネンの抽出液では、トリプタンスリンの付近に複数の化合物が測定されており、これらの化合物が静菌作用に好影響を及ぼしているものと推測される。これに対し、エタノールにより抽出では、d-リモネンの場合とは異なる分で多数の化合物が測定された。これらの化合物は、静菌作用に貢献しないうえに、着色の原因物質になると推定される。この結果より、静菌作用については、エタノール抽出よりもリモネン抽出によるトリプタンスリン抽出液が優れていることが判る。 According to the chart measured by the above HPLC device, in the d-limonene extract, multiple compounds were measured near tryptanthrin, and it is speculated that these compounds have a favorable effect on the bacteriostatic action. be done. In contrast, extraction with ethanol measured a number of compounds at different fractions than in the case of d-limonene. These compounds do not contribute to the bacteriostatic action and are presumed to be the causative agents of coloration. From these results, it can be seen that the tryptanthrin extract obtained by limonene extraction is superior to ethanol extraction in terms of bacteriostatic action.
また、上記リモネンの抽出時に、アスコルビン酸を加えても良い。アスコルビン酸の添加量は、d-リモネンに対する溶解度が0.01%以下であるため、アスコルビン酸の結晶が沈殿する0.01%以上とし、飽和状態を保つものとする。また、アスコルビン酸の添加は、藍葉の添加と同時に行うのが好ましい。なお、実験の結果、上記24時間の抽出では、トリプタンスリンの抽出量には影響を及ぼさないことが判った。 Further, ascorbic acid may be added during the extraction of limonene. Since the solubility of ascorbic acid in d-limonene is 0.01% or less, the amount of ascorbic acid to be added should be 0.01% or more at which crystals of ascorbic acid are precipitated, and a saturated state should be maintained. In addition, ascorbic acid is preferably added at the same time as indigo leaves are added. As a result of the experiment, it was found that the 24-hour extraction did not affect the amount of tryptanthrin extracted.
本発明において、d-リモネンに殆ど溶けないアスコルビン酸を添加したのは、次の理由による。リモネンには光反応・酸化変性や自動酸化が生じるところ、アスコルビン酸は、空気中では酸化型のデヒドロアスコルビン酸として存在する量が多く、共存するリモネンや藍葉の成分等よりもヒドロキシラジカルとの反応性が高いため、共存する化合物の酸化変性を抑制する抗酸化剤として機能する。 The reason for adding ascorbic acid, which is almost insoluble in d-limonene, in the present invention is as follows. Whereas limonene undergoes photoreaction, oxidative denaturation, and autoxidation, ascorbic acid exists in large amounts in the air as oxidized dehydroascorbic acid, and reacts with hydroxyl radicals more than coexisting limonene and components of indigo leaves. It functions as an antioxidant that suppresses oxidative degeneration of coexisting compounds due to its high potency.
また、トリプタンスリン抽出液を布の染に用いる場合において当該染の後に日光下で風乾するとき、アスコルビン酸の光反応によるラジカルの産生が染における「染むら」の原因となる色素に対して分解作用を示し、退色を誘発する。即ち、アスコルビン酸が漂白剤として機能する。 In addition, when the tryptanthrin extract is used for dyeing cloth, when it is air-dried in sunlight after the dyeing, the production of radicals due to the photoreaction of ascorbic acid decomposes the pigment that causes "uneven dyeing" in the dyeing. It acts and induces fading. That is, ascorbic acid functions as a bleaching agent.
更に、上記日光下での風乾において、前記リモネンも酸化・光反応により揮発性の生成物やジカルボニル等の不安定な反応性の高い生成物を生じさせるが、これらのリモネン酸化物は、アスコルビン酸により分解され得る。 Furthermore, in the air drying under sunlight, the limonene also generates volatile products and unstable highly reactive products such as dicarbonyl due to oxidation and photoreaction, but these limonene oxides are ascorbic Can be decomposed by acid.
なお、トリプタンスリン等の有効成分であるアルカロイド類よりも、リモネンからの生成物の方がラジカルとの反応性が極めて高いため、アスコルビン酸の光反応によるトリプタンスリンの分解については殆ど考慮しなくても良い。すなわち、アスコルビン酸の添加による藍葉の抗菌有効成分への影響は低い。 Since the product from limonene is much more reactive with radicals than alkaloids, which are the active ingredients of tryptanthrin, the decomposition of tryptanthrin due to the photoreaction of ascorbic acid should not be considered. Also good. That is, the addition of ascorbic acid has little effect on the antibacterial active ingredients of indigo leaves.
このように、トリプタンスリン抽出時にアスコルビン酸を添加することで、トリプタンスリン抽出液に対して極めて有用な作用効果をもたらすことが判った。 Thus, it was found that the addition of ascorbic acid during the tryptanthrin extraction brings about extremely useful effects on the tryptanthrin extract.
なお、上記実施の形態では、藍葉をリモネン溶液に浸漬することでトリプタンスリンを抽出したが、藍葉に対してリモネン容器を点滴又は噴霧することで、当該藍葉に対してリモネン溶液を接触させ、この滴を循環させながらトリプタンスリンの抽出を行うようにしても良い。即ち、リモネン溶液が藍葉に接触することで抽出が行われることから、このような状態を形成する接触方法であれば、これらに限定されるものではない。
In the above embodiment, the tryptanthrin was extracted by immersing the indigo leaves in the limonene solution. The tryptanthrin may be extracted while the droplets are circulated. That is, since extraction is performed by bringing the limonene solution into contact with indigo leaves, the contact method is not limited to these as long as it forms such a state.
Claims (1)
ロウイルスに感染した細胞に用いるノロウイルス不活性化方法(ただし、人間を治療する方法を除く。)
A method for inactivating norovirus using a tryptanthrin-containing indigo extract consisting of a d-limonene extract of indigo leaf tryptanthrin for cells infected with norovirus (however, methods for treating humans are excluded).
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP2018070445A JP7321410B2 (en) | 2018-03-31 | 2018-03-31 | Norovirus inactivation method |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP2018070445A JP7321410B2 (en) | 2018-03-31 | 2018-03-31 | Norovirus inactivation method |
Publications (2)
Publication Number | Publication Date |
---|---|
JP2019182745A JP2019182745A (en) | 2019-10-24 |
JP7321410B2 true JP7321410B2 (en) | 2023-08-07 |
Family
ID=68339510
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
JP2018070445A Active JP7321410B2 (en) | 2018-03-31 | 2018-03-31 | Norovirus inactivation method |
Country Status (1)
Country | Link |
---|---|
JP (1) | JP7321410B2 (en) |
Citations (8)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JP2001031581A (en) | 1998-06-30 | 2001-02-06 | Hayashibara Biochem Lab Inc | Bioactive extract |
JP2004189732A (en) | 2002-11-28 | 2004-07-08 | Tohoku Techno Arch Co Ltd | Antimicrobially active material obtained from polygonum tinctorium and various compositions containing the same |
WO2009078447A1 (en) | 2007-12-17 | 2009-06-25 | Adept Co., Ltd. | Anti-norovirus agent, anti-influenza-virus agent, and anti-viral treatment method using each of the agents |
JP2011046636A (en) | 2009-08-26 | 2011-03-10 | Takex Labo:Kk | Antiviral composition and utilization thereof |
WO2012124743A1 (en) | 2011-03-14 | 2012-09-20 | サンスター株式会社 | Method for producing polygonum tinctorium extract |
JP2013047196A (en) | 2011-08-29 | 2013-03-07 | Settsu Seiyu Kk | Norovirus-killing composition |
JP2017001969A (en) | 2015-06-05 | 2017-01-05 | 横浜ゴム株式会社 | Method for producing tryptanthrin |
WO2018062543A1 (en) | 2016-09-29 | 2018-04-05 | 久幸 吉田 | Method for producing indigo leaf solution containing tryptanthrin |
-
2018
- 2018-03-31 JP JP2018070445A patent/JP7321410B2/en active Active
Patent Citations (8)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JP2001031581A (en) | 1998-06-30 | 2001-02-06 | Hayashibara Biochem Lab Inc | Bioactive extract |
JP2004189732A (en) | 2002-11-28 | 2004-07-08 | Tohoku Techno Arch Co Ltd | Antimicrobially active material obtained from polygonum tinctorium and various compositions containing the same |
WO2009078447A1 (en) | 2007-12-17 | 2009-06-25 | Adept Co., Ltd. | Anti-norovirus agent, anti-influenza-virus agent, and anti-viral treatment method using each of the agents |
JP2011046636A (en) | 2009-08-26 | 2011-03-10 | Takex Labo:Kk | Antiviral composition and utilization thereof |
WO2012124743A1 (en) | 2011-03-14 | 2012-09-20 | サンスター株式会社 | Method for producing polygonum tinctorium extract |
JP2013047196A (en) | 2011-08-29 | 2013-03-07 | Settsu Seiyu Kk | Norovirus-killing composition |
JP2017001969A (en) | 2015-06-05 | 2017-01-05 | 横浜ゴム株式会社 | Method for producing tryptanthrin |
WO2018062543A1 (en) | 2016-09-29 | 2018-04-05 | 久幸 吉田 | Method for producing indigo leaf solution containing tryptanthrin |
Non-Patent Citations (1)
Title |
---|
佐々木健郎,蓼藍の成分と機能性について -機能性を併せ持つ染料の科学-,東北薬科大学研究誌,2015年,Vol. 62,pp. 25-37 |
Also Published As
Publication number | Publication date |
---|---|
JP2019182745A (en) | 2019-10-24 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
Deliorman Orhan et al. | Biological activities of Vitis vinifera L. leaves | |
Abeysekera et al. | In vitro antioxidant properties of leaf and bark extracts of Ceylon cinnamon (Cinnamomum zeylanicum Blume). | |
Zhou et al. | UPLC-ESI-MS/MS based identification and antioxidant, antibacterial, cytotoxic activities of aqueous extracts from storey onion (Allium cepa L. var. proliferum Regel) | |
Joaquín-Ramos et al. | Phenolic compounds, antioxidant properties and antifungal activity of jarilla (Barkleyanthus salicifolius ENT# 91; KunthENT# 93; H. Rob & Brettell) | |
Abouzeed et al. | Identification of phenolic compounds, antibacterial and antioxidant activities of raisin extracts | |
Moghaddam et al. | In vitro antioxidant and antibacterial activity of various extracts from exocarps and endocarps of walnut. | |
Melo et al. | Antioxidant capacity and antimicrobial activity of commercial samples of guava leaves (Psidium guajava) | |
JP7321410B2 (en) | Norovirus inactivation method | |
Rita et al. | Total flavonoid and phenolic contents of n-butanol extract of Samanea saman leaf and the antibacterial activity towards Escherichia coli and Staphylococcus aureus | |
KR20120010688A (en) | Skin whitening, anti-aging, antioxidant and antimicrobial cosmetic composition | |
JP2000212092A (en) | Antivirus and antibacterial agent | |
Aissani et al. | Antioxidant potential and antimicrobial activity of Ailanthus altissima (Mill.) Swingle extracts against Pseudomonas aeruginosa | |
JP6389492B2 (en) | Method for producing tryptanthrin-containing indigo leaf solution | |
CN115500355B (en) | Control of downy mildew of litchi by Podophyllotoxin and Gentisic acid | |
Wafa et al. | Antioxidant, anti-inflammatory and antimicrobial activities of aqueous and methanolic extract of Rosmarinus eriocalyx Jord. & Fourr. | |
Zulkamal et al. | Bioactivity of clitoria ternatea crude extracts against pathogenic bacteria | |
JP2021169444A (en) | Influenza virus inhibitor | |
Dibala et al. | Chemical composition, antioxidant and antibacterial properties of extracts from ocimum americanum L. against multi-resistant food bacteria | |
Roshanak et al. | Evaluation of chlorophyll content, antioxidant activity and antimicrobial effect of Dandelion leaves extract. | |
JP7432218B2 (en) | Uses of primrose extracts | |
KR102120005B1 (en) | A composition having anti-oxidation or anti-bacterial activity comprising Glehnia littoralis extracts | |
Nikomtat et al. | Inhibition of Inula cappa (Ham. ex D. Don) DC. extracts on herpes simplex virus infection in vitro | |
Shopova et al. | Antioxidant capacity of herbal teas from Bulgarian market. | |
CN108546590A (en) | Application process of Fructus Perillae quintessence oil during citrus storage at normal temperature | |
Suraksha et al. | “Comparative evaluation of cytotoxicity of three herbal endodontic irrigants at three intervals of time”–An in vitro study |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
A521 | Request for written amendment filed |
Free format text: JAPANESE INTERMEDIATE CODE: A523 Effective date: 20180524 |
|
A621 | Written request for application examination |
Free format text: JAPANESE INTERMEDIATE CODE: A621 Effective date: 20210331 |
|
A521 | Request for written amendment filed |
Free format text: JAPANESE INTERMEDIATE CODE: A523 Effective date: 20210925 |
|
A131 | Notification of reasons for refusal |
Free format text: JAPANESE INTERMEDIATE CODE: A131 Effective date: 20220510 |
|
A601 | Written request for extension of time |
Free format text: JAPANESE INTERMEDIATE CODE: A601 Effective date: 20220708 |
|
A521 | Request for written amendment filed |
Free format text: JAPANESE INTERMEDIATE CODE: A523 Effective date: 20220909 |
|
A131 | Notification of reasons for refusal |
Free format text: JAPANESE INTERMEDIATE CODE: A131 Effective date: 20230117 |
|
A521 | Request for written amendment filed |
Free format text: JAPANESE INTERMEDIATE CODE: A523 Effective date: 20230301 |
|
TRDD | Decision of grant or rejection written | ||
A01 | Written decision to grant a patent or to grant a registration (utility model) |
Free format text: JAPANESE INTERMEDIATE CODE: A01 Effective date: 20230418 |
|
A61 | First payment of annual fees (during grant procedure) |
Free format text: JAPANESE INTERMEDIATE CODE: A61 Effective date: 20230426 |
|
R150 | Certificate of patent or registration of utility model |
Ref document number: 7321410 Country of ref document: JP Free format text: JAPANESE INTERMEDIATE CODE: R150 |
|
S201 | Request for registration of exclusive licence |
Free format text: JAPANESE INTERMEDIATE CODE: R314201 |
|
R360 | Written notification for declining of transfer of rights |
Free format text: JAPANESE INTERMEDIATE CODE: R360 |
|
R360 | Written notification for declining of transfer of rights |
Free format text: JAPANESE INTERMEDIATE CODE: R360 |
|
R371 | Transfer withdrawn |
Free format text: JAPANESE INTERMEDIATE CODE: R371 |
|
S201 | Request for registration of exclusive licence |
Free format text: JAPANESE INTERMEDIATE CODE: R314201 |
|
S531 | Written request for registration of change of domicile |
Free format text: JAPANESE INTERMEDIATE CODE: R313531 |
|
R350 | Written notification of registration of transfer |
Free format text: JAPANESE INTERMEDIATE CODE: R350 |